Inventor · disambiguated record
Jonathan Richard Anthony Roffey
Also filed as: ROFFEY JONATHAN R A · ROFFEY JONATHAN RICHARD A · ROFFEY JONATHAN RICHARD ANTHON · ROFFEY JONATHAN RICHARD ANTHONY
14 granted patents·6 pending applications·163 citations·filing 1999–2009
92Inventor score
Technology areasA61P
Top patents by PatentIndex Score
20 records- 0193US6706750B1Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal applicationVERNALIS RES LTD·Filed 2000·Granted Mar 16, 2004·68 cites·23 claims
- 0277US7323473B2Condensed indoline derivatives and their use as 5-HT, in particular 5-HT2C, receptor ligandsVERNALIS RES LTD·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 0377US7323487B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 0477US7323486B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 0576US6962939B1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2000·Granted Nov 8, 2005·5 cites·14 claims
- 0672US6433175B1Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonistsVERNALIS RES LTD·Filed 1999·Granted Aug 13, 2002·32 cites·27 claims
- 0768US6380238B1Indoline derivatives as 5-HT2B and or 5-HTC receptor ligandsVERNALIS RES LTD·Filed 1999·Granted Apr 30, 2002·27 cites·23 claims
- 0866US2008125455A1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, Receptor ligandsVERNALIS RES LTD·Filed 2007·Application pending·0 cites
- 0966US2008114018A1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2007·Application pending·0 cites
- 1066US2008090858A1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2007·Application pending·0 cites
- 1161US7173056B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2005·Granted Feb 6, 2007·0 cites·13 claims
- 1261US7166613B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligandsVERNALIS RES LTD·Filed 2005·Granted Jan 23, 2007·0 cites·11 claims
- 1361US7166632B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2005·Granted Jan 23, 2007·0 cites·10 claims
- 1457US6365598B1Pyrroloquinolines for treatment of obesityVERNALIS RES LTD·Filed 1999·Granted Apr 2, 2002·15 cites·29 claims
- 1556US6552062B1Indazole derivatives with 5-HT2 receptor activityVERNALIS RES LTD·Filed 1999·Granted Apr 22, 2003·13 cites·24 claims
- 1655US2009181939A1Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated DisordersVERNALIS RES LTD·Filed 2009·Application pending·0 cites
- 1752US7022707B2Piperazine derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Apr 4, 2006·0 cites·43 claims
- 1849US2007173486A1Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrsVERNALIS RES LTD·Filed 2004·Application pending·0 cites
- 1945US2002143020A1Novel piperazine derivativesFiled 2001·Application pending·0 cites
- 2043US7098337B21,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivativesVERNALIS RES LTD·Filed 2003·Granted Aug 29, 2006·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →